What is HCA announcing with this 8-K filing?

HCA is announcing two main items: preliminary third-quarter 2004 financial results and the approval of a tender offer to repurchase up to 61,000,000 shares of its common stock.

What is the "Dutch" auction tender offer, and what is the price range?

A "Dutch" auction tender offer allows shareholders to indicate the price at which they are willing to sell their shares, within a specified range. HCA's offer allows shareholders to tender shares at a price not greater than $41.00 nor less than $35.00 per share.

How will HCA finance this tender offer and its refinancing plans?

HCA has secured conditional financing commitments. Approximately $1.5 billion is expected from a short-term loan facility (JPMorgan/Merrill Term Facility), and approximately $1 billion will be drawn under a new credit facility (JPMorgan Revolving Facility) as part of refinancing its existing credit facility. The total commitments from JPMorgan Chase are up to $2.25 billion for refinancing and general corporate purposes, and an additional $1.5 billion commitment from JPMorgan and Merrill Lynch is specifically for the tender offer.

Are there any significant conditions attached to the financing commitments?

Yes, the financing is subject to customary conditions, including the repayment of HCA's existing credit facility, no material adverse changes in HCA's financial condition, and maintaining specific minimum credit ratings (BB+ from S&P and Ba2 from Moody's with a stable outlook).

HCA 8-K: Earnings & Results & Regulation FD

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on October 13, 2004, primarily announcing two significant events. First, the company released preliminary results for its third quarter ended September 30, 2004. While specific figures are not detailed within this filing's text, this announcement provides investors with an early look at HCA's operational and financial performance during the period. Second, and of considerable note for investors, HCA's Board of Directors approved a modified "Dutch" auction tender offer to repurchase up to 61,000,000 shares of its common stock. This offer allows shareholders to sell their shares at a price within a specified range of $35.00 to $41.00 per share. The company has secured significant financing commitments, including a $1.5 billion term loan facility and a $1.75 billion revolving credit facility from JPMorgan Chase, along with an additional $1.5 billion term loan facility from JPMorgan and Merrill Lynch, to fund this substantial share repurchase and refinance existing debt.

Key Highlights

1HCA announced preliminary results for the third quarter ended September 30, 2004.
2HCA's Board of Directors approved a modified "Dutch" auction tender offer to repurchase up to 61,000,000 shares of common stock.
3The tender offer allows shareholders to tender shares at a price between $35.00 and $41.00 per share.
4The company secured conditional financing commitments totaling approximately $2.75 billion from JPMorgan Chase for refinancing existing debt and general corporate purposes, including potential share redemptions.
5HCA also secured conditional commitments for a $1.5 billion senior term loan facility from JPMorgan and Merrill Lynch, specifically to finance the tender offer.
6The financing arrangements include a combination of term loans and revolving credit facilities with maturities of five and six months respectively for the tender offer financing, and five years for the refinancing facilities.
7Key conditions for the financing include the repayment of existing credit facilities, absence of material adverse changes, and minimum credit ratings from Standard & Poor's (BB+) and Moody's (Ba2).

HCA Healthcare, Inc. 8-K Report, Financial Results (Oct 13, 2004)

Summary

Key Highlights

Frequently Asked Questions